Dasatinib for the treatment of Philadelphia chromosome-positive leukaemias (vol 16, pg 679, 2007)

被引：0
|
作者：
Jabbour
Cortes
Kantarjian
机构：
来源：
EXPERT OPINION ON INVESTIGATIONAL DRUGS | 2007年 / 16卷 / 07期
关键词：
D O I：
10.1517/13543784.16.7.1135
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1135 / 1135
页数：1
相关论文
共 50 条
  • [1] Dasatinib for the treatment of Philadelphia chromosome-positive leukaemias
    Jabbour, Elias
    Cortes, Jorge
    Kantarjian, Hagop
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (05) : 679 - 687
  • [2] Dasatinib for the treatment of Philadelphia chromosome-positive leukemias
    Santos, Fabio P. S.
    Cortes, Jorge
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (16) : 2381 - 2395
  • [3] Dasatinib Treatment for Philadelphia Chromosome-positive Leukemias Practical Considerations
    Khoury, Hanna Jean
    Guilhot, Francois
    Hughes, Timothy P.
    Kim, Dong-Wook
    Cortes, Jorge E.
    CANCER, 2009, 115 (07) : 1381 - 1394
  • [4] Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias
    Talpaz, Moshe
    Shah, Neil P.
    Kantarjian, Hagop
    Donato, Nicholas
    Nicoll, John
    Paquette, Ron
    Cortes, Jorge
    O'Brien, Susan
    Nicaise, Claude
    Bleickardt, Eric
    Blackwood-Chirchir, M. Anne
    Iyer, Vishwanath
    Chen, Tai-Tsang
    Huang, Fei
    Decillis, Arthur P.
    Sawyers, Charles L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (24): : 2531 - 2541
  • [5] Dasatinib for the treatment of Philadelphia chromosome-positive chronic myelogenous leukaemia after imatinib failure
    Hochhaus, Andreas
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (18) : 3257 - 3264
  • [6] Dasatinib as an investigational drug for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in adults
    Brattas, Marte Karen
    Reikvam, Hakon
    Tvedt, Tor Henrik Anderson
    Bruserud, Oystein
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (05) : 411 - 420
  • [7] Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemia
    Luskin, Marlise R.
    Murakami, Mark A.
    Keating, Julia
    Flamand, Yael
    Winer, Eric S.
    Garcia, Jacqueline S.
    Stahl, Maximilian
    Stone, Richard M.
    Wadleigh, Martha
    Jaeckle, Stella L.
    Hagopian, Ella
    Weinstock, David M.
    Liegel, Jessica
    Mcmasters, Malgorzata
    Wang, Eunice S.
    Stock, Wendy
    Deangelo, Daniel J.
    BLOOD, 2025, 145 (06) : 577 - 589
  • [8] Severe thrombocytopenia after dasatinib treatment in a patient with Philadelphia chromosome-positive chronic myeloid leukemia
    Chen, Runzhe
    Wang, Fei
    Zhang, Xiaoping
    Gao, Chong
    Chen, Baoan
    OncoTargets and Therapy, 2015, 8 : 955 - 957
  • [9] Bosutinib for the treatment of Philadelphia chromosome-positive leukemias
    Varallo-Rodriguez, Cristina
    Freyer, Craig W.
    Ontiveros, Evelena P.
    Griffiths, Elizabeth A.
    Wang, Eunice S.
    Wetzlerz, Meir
    EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (05): : 599 - 608
  • [10] Bosutinib treatment for Philadelphia chromosome-positive leukemias
    Bethelmie-Bryan, Beverly
    Lord, Katharine
    Holloway, Stacie
    Khoury, Hanna Jean
    FUTURE ONCOLOGY, 2014, 10 (02) : 179 - 185
12345